RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +6.4% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 133 | +9 | 66.02M | $7.35B | +14 | −4 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | — | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | — | 11.86M | $1.24B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.63M | +17.8% | $851.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.63M | +17.8% | $851.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 5.17M | — | $576.60M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.90M | +1.3% | $322.96M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 2.90M | +1.3% | $322.96M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 1.15M | -4.6% | $127.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 951.88K | +2.0% | $106.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 163.76K | +37.9% | $18.28M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 57.25K | +41.0% | $6.39M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 38.69K | -41.6% | $4.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 34.35K | -74.9% | $3.83M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 8.03K | +27.2% | $896,036 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 6.66K | +13.2% | $742,765 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 6.66K | +13.2% | $742,765 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 4.08K | Nuevo | $455,480 | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 3.56K | +4.6% | $396,885 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 3.56K | +4.6% | $396,885 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $455,480 | 0.0% |
Posición cerrada
| D. E. Shaw & Co. | $446,870 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 495 tenedores, 115.11M acciones, $7.19B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.